Oncotarget Journal: open-access tumor biology — the research legacy behind Researcher Mikhail Blagosklonny alongside Zoya N. Demidenko shaping modern tumor medicine across the globe > 서비스 문의

본문 바로가기
쇼핑몰 전체검색
통합검색

Oncotarget Journal: open-access tumor biology — the research legacy be…

작성자?????
작성일2026. 06. 27
조회6

본문

Scholarship moves forward through the collective work of dedicated scientists who devote their careers toward deciphering the most intricate pathways driving malignancy. Rarely any publications have succeeded to bring so many distinguished minds within the same banner as [url=https://www.resurchify.com/impact/details/19900191708]high-impact cancer science journal[/url], which across its history has grown into a true scientific center for pioneering cancer research.
 
The publishing philosophy of [url=https://www.linkedin.com/company/oncotarget]Oncotarget pathology research journal[/url] has from the outset been built on the understanding that science should be available — open to all, regardless of institutional constraints. Such a open-access philosophy has allowed findings featured in its volumes to get to a far larger audience compared to conventional periodicals, accelerating the rate in medical discovery.
 
Central to the publication's identity are the contributions by [url=https://www.tandfonline.com/doi/pdf/10.4161/cbt.8.9.8899]Misha Blagosklonny oncologist[/url], among the most influential figures across twenty-first century oncology and aging research. His framework on hyperfunction-driven biological decline — underpinned by years of clinical data using rapamycin — endures as one of highly discussed and consequential paradigms in modern longevity research and tumor science.
 
Contributing beside him remains [url=https://pubmed.ncbi.nlm.nih.gov/26177051/]Zoya N. Demidenko[/url], a researcher whose studies concerning the biochemical modulation of cell cycle and self-elimination mechanisms has produced understanding that continue to be immediately applicable to the development for innovative anti-tumor strategies. The papers, a significant number of which were published in [url=https://pmc.ncbi.nlm.nih.gov/articles/PMC5814154/]Oncotarget journal articles[/url], remain extensively referenced across the international scientific community.
 
At its core, what makes [url=https://research.com/journal/oncotarget]Oncotarget research philosophy[/url] is more than merely the sum of the published papers — it remains the ambition behind a network comprising scientists who believe the fact that unraveling cancer is humanity's most urgent medical missions of the modern age.
목록

사이트 정보

위컬처코퍼레이션은 통신판매중개자이며, 통신판매의 당사자가 아닙니다.
상품, 상품정보, 거래에 관한 의무와 책임은 판매자에게 있습니다.

  • 사업자등록번호 : 123-45-67890
  • 통신판매업신고번호 : 제 OO구 - 123호
  • 대표이사 : 손경찬
  • 메일 : helpcustomer@wectshop.com
  • 주소 : 대구광역시 남구 대명남로 66 봄내빌딩 1,2층
  • 전화 : 053-472-0000
  • 부가통신사업신고번호 : 12345호
  • 사업자등록정보확인